Clinical Trial Update: An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab Treatment [Phase 3]

View source ↗

Summary

An extension Phase 3 trial update for multiple sclerosis to assess physical function and provide continued treatment with ocrelizumab; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis | Phase 3 | Status: RECRUITING